RxDoctor Payments Data

Patricio Escalona

Psychiatry · Albuquerque, NMNPI 1073626156

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $402,210 of the $486,639 with a category attached, or 82.7%. Alkermes, Inc. accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Among psychiatry clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$486,639in general payments, 2019–2025

Across 463 payments — averaging $1051.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$486K
  • Teva Pharmaceuticals USA, Inc.$523

What the payments were for

  • Consulting fees$23,5905%
  • Speaking & faculty fees$402,21083%
  • Travel & lodging$47,96810%
  • Food & beverage$12,8703%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alkermes, Inc.461$486,116
Teva Pharmaceuticals USA, Inc.2$523

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$486,639 in reported general payments places this provider in the 95th percentile of 174 psychiatry providers in New Mexico.

See all psychiatry providers in New Mexico

Other psychiatry in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →